DOAJ
open access
Health claims about cannabidiol (CBD) at the point-of-sale in three U.S. states with disparate cannabis policies
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Cannabidiol (CBD) in Healthy Volunteers#1139759
- Cannabidiol for Treatment Resistant Depression#838914
- Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study#883640
- Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial#968476
- Cannabis Warning Content Analysis#296109
Record · ID 238471
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive